CD36 and type 2 diabetes mellitus: In contrast to healthy subjects, most regular consumption trials with patients suffering from type 2 diabetes or impaired glucose tolerance found lower concentrations of ICAM-1 [64,66] and P-selectin in serum or plasma [64] and a reduced expression of VLA-4, CD36, and CD40 on monocytes [64].